Filter your search
Drug Delivery Market ReportsX
Kalorama has the information you need on the drug delivery market, including the needle-free systems, transdermal and transmucosal, and infusion pump segments. Our studies describe the market opportunity, the connection to other medical care channels, and the future direction of the market and its segments. Whether you seek market information for dispensing drugs through intra-arterial, intravenous, subcutaneous, epidural, needle-free jet injector, or other methods, Kalorama has the industry intelligence you need.
- $2,995.00 – $5,990.00With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets. Biopharmaceutical products are […]September 1, 2009$995.00 – $7,990.00Pharmaceutical excipients are substances, other than the pharmacologically active drug or prodrug, which are included in the manufacturing process or are contained in the finished pharmaceutical product dosage form. Excipients provide enhanced functionality to the pharmaceuticals, aid the innovations in the drug development and help improve patent life as well. Excipients make the products more […]February 1, 2008$2,500.00 – $5,000.00An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure volumes. But as this market continues […]July 1, 2007$4,995.00 – $9,990.00Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals that are sold along with those technologies. Kalorama’s Drug Delivery Systems focuses on these technologies. This offer is for the entire 4 volumes of Kalorama’s 2nd […]April 1, 2007$2,495.00 – $4,990.00New biological treatments are being developed at a record pace, but their potential could be compromised by a significant obstacle: the delivery of these drugs into the body. Pharmaceutical delivery is now nearly as important as product. Kalorama’s Drug Delivery Markets Series covers these new systems. The fourth volume of this series, Kalorama’s Drug Delivery […]April 1, 2007$2,495.00 – $4,990.00The lungs are considered by many to be the best alternative for drugs needing to bypass the gastrointestinal tract. With advancing technology, the practice of utilizing the huge surface area of the lungs to delivery drugs into the blood circulation has been slowly transforming into reality. The pulmonary drug delivery market reached $25.5 billion in […]March 1, 2007$2,995.00 – $4,990.00Fueled by the promise of needle-free mechanisms for vaccine distribution and other pharmaceutical uses, the implantable/injectable drug delivery market is growing rapidly. The development of better delivery systems in conjunction with the discovery of novel pharmacological compounds will lead to continued growth. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime […]February 1, 2007$995.00 – $7,000.00The orthopedic drug market is a highly competitive market and, in some areas, the competitive environment is being shaped by increasing levels of generic competition. Several large pharmaceutical companies compete in the orthopedic drug market, including Abbott, Eli Lilly, GlaxoSmithKline, Merck, Novartis, and Pfizer among others, and several other suppliers, such as Serono, NovoNordisk, Amgen, […]October 1, 2006$3,550.00 – $7,000.00This complete re-evaluation of the Men’s Health market focuses on the following prescription drug treatment segments: Men’s Cancer Men’s Sexual Dysfunction Men’s Sexually Transmitted Diseases Men’s Urinary Conditions Andropause The report covers drugs used for the treatment of prostate cancer, testicular cancer, impotence, premature ejaculation, and benign prostatic hyperplasia (BPH), urinary incontinence, and STD’s such […]May 1, 2006$3,500.00 – $7,000.00There are hundreds of drugs in Phase III clinical trials, of which almost 200 of them may gain market approval from the FDA in the coming 5 years. Which drugs will make it and how these drugs impact existing pharmaceutical markets in terms of overall size and competitive share is one of the most difficult […]March 1, 2006